Ahead of Apple's upcoming hardware keynote, reports reveal that the tech giant is actively evaluating continuous heart rate tracking for the Apple Watch 12 and Apple Watch Ultra 4. While existing Apple Watch hardware measures resting heart rate intermittently every few minutes to conserve battery, moving to true 24/7 optical biometric capture marks a major strategic shift toward competing directly with dedicated fitness trackers like Oura Ring and Whoop.
Continuous photoplethysmography (PPG) sensing unlocks high-frequency heart rate variability (HRV) calculations around the clock. Rather than sampling pulses in isolated windows or exclusively during manually triggered workouts, all-day continuous monitoring provides unbroken biometric trends. This high-density data stream lays the technical groundwork for Apple to introduce a native readiness score—a long-sought recovery index that compares physical strain against sleep quality. You can see how sensor arrays capture vital signs in our sensor matrix or check your current casing generation with our model identifier.
Preserved Benefit: Constant optical monitoring enables instantaneous detection of health anomalies, fever onset, and autonomic nervous system fatigue through continuous HRV tracking.
Explicit Trade-Off: Continuous optical biosensor illumination puts heavy demands on the battery cell, requiring aggressive SiP power optimizations to maintain all-day runtime.
The defining technical hurdle for continuous biometrics has always been power consumption. While dedicated passive trackers operate for several days on a single charge without high-refresh OLED displays, Apple Watch has historically targeted an 18-hour daily baseline. Delivering uncompromised 24/7 health tracking will require next-generation micro-LED or low-power SiP architectures to avoid battery penalties.
To evaluate how your current wearable holds up under intensive fitness tracking workloads, run our Apple Watch battery calculator or discover customizable fitness designs in our watch face gallery.